Research use only · Not for human or veterinary use
Each vial ships with batch documentation for the neuropeptide complex, plus a Certificate of Analysis documenting peptide fraction content and quality. Ready for the bench. Cerebrolysin is a standardized low-molecular-weight neuropeptide fraction derived from purified pig brain proteins via enzymatic digestion. Batch quality, peptide content, and sterility testing are documented on the signed Certificate of Analysis that ships with your vial.
Cerebrolysin is a standardized mixture of low-molecular-weight biologically active neuropeptides and amino acid fragments derived from purified pig brain proteins via enzymatic digestion. Developed in Europe in the 1950s, it has been used clinically in Europe and Asia for neurological conditions including Alzheimer’s disease, stroke recovery, and traumatic brain injury.
The neuropeptide fraction (approximately 25% of the preparation by weight) contains small peptides with proposed neurotrophic factor-like activity. Proposed mechanisms include NGF-like, BDNF-like, and CNTF-like signaling, though the specific active molecular entities within the complex are not fully characterized.
Note: Cerebrolysin is a complex biological preparation, not a synthetic single-compound peptide. COA documents peptide fraction content and quality testing rather than single-molecule purity. This product is for laboratory research use only.
Each vial ships with batch documentation for the neuropeptide complex, plus a Certificate of Analysis documenting peptide fraction content and quality. Ready for the bench. Cerebrolysin is a standardized low-molecular-weight neuropeptide fraction derived from purified pig brain proteins via enzymatic digestion. Batch quality, peptide content, and sterility testing are documented on the signed Certificate of Analysis that ships with your vial.
Cerebrolysin is a standardized mixture of low-molecular-weight biologically active neuropeptides and amino acid fragments derived from purified pig brain proteins via enzymatic digestion. Developed in Europe in the 1950s, it has been used clinically in Europe and Asia for neurological conditions including Alzheimer’s disease, stroke recovery, and traumatic brain injury.
The neuropeptide fraction (approximately 25% of the preparation by weight) contains small peptides with proposed neurotrophic factor-like activity. Proposed mechanisms include NGF-like, BDNF-like, and CNTF-like signaling, though the specific active molecular entities within the complex are not fully characterized.
Note: Cerebrolysin is a complex biological preparation, not a synthetic single-compound peptide. COA documents peptide fraction content and quality testing rather than single-molecule purity. This product is for laboratory research use only.
Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons
PubMed · PubMed · 11356013Cerebrolysin in Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial with a Neurotrophic Agent
PubMed · PubMed · 25858564At Revvd Research, quality comes first. Our peptides are produced using advanced manufacturing processes and verified through comprehensive testing protocols to deliver dependable results for research applications.
Produced
50mg / 10mg / 10mg per vial
10mg / vial
5mg / 5mg per vial
5mg / 5mg per vial
Featured Collection – Premium purity compounds crafted with consistency, precision, and quality in mind.
30-day money back · Free shipping over $150 · 2-day shipping
